Related Experiment Video
Updated: Mar 25, 2026
10:35
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
8.7K
Immune Globulin Intravenous: Myasthenia Gravis (Acute Exacerbation)
Joyce A Generali1, Dennis J Cada2
1Editor-in-Chief, Hospital Pharmacy , and Clinical Professor, Emeritus, Department of Pharmacy Practice, University of Kansas, School of Pharmacy , Kansas City/Lawrence, Kansas ,
Hospital Pharmacy
|February 26, 2016
Summary
This guide helps healthcare professionals find and evaluate off-label drug uses not approved by the US Food and Drug Administration (FDA). It aids in determining the rationality of these uses in patient care scenarios using published literature.
Area of Science:
- Pharmacy
- Pharmacology
- Evidence-Based Medicine
Background:
- Off-label drug use is common in clinical practice.
- Information on unapproved drug indications can be fragmented.
- Practitioners need reliable resources to assess off-label drug efficacy and safety.
Purpose of the Study:
- To introduce a resource for off-label drug information.
- To guide healthcare professionals in evaluating off-label drug uses.
- To facilitate evidence-based decision-making for unapproved indications.
Main Methods:
- Extraction of information from the "Off-Label Drug Facts" publication.
- Literature review to identify published studies on off-label drug uses.
- Guidance on assessing the rationality of specific off-label uses.
Main Results:
- Provides a practitioner-oriented resource for off-label drug information.
- Enables quick identification of published studies on unapproved drug uses.
- Offers references for comprehensive literature review.
Conclusions:
- "Off-Label Drug Facts" supports informed clinical decision-making.
- Enhances the rational use of medications in patient care.
- Facilitates evidence-based practice for unapproved drug indications.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
01:15Myasthenia Gravis: Diagnostic Tests
3.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K
01:14Myocarditis III: Medical Management
313
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
313
01:22Myocarditis IV: Nursing Management
348
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
348
01:26Anticholinesterase Agents: Poisoning and Treatment
1.9K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
01:26Pharmaceutical Poisoning: Treatment Strategies
147
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
147